Benralizumab | search
Click here to view Benralizumab news from 60+ newspapers.
Bookmark or Share- Benralizumab versus Mepolizumab for Eosinophilic ...Benralizumab is a humanized, afucosylated monoclonal antibody with high affinity and specificity for the human interleukin-5 receptor α subunit (interleukin-5Rα) expressed on eosinophils 14 and...
- Severe Eosinophilic Asthma Treatment | FASENRA® (benralizumab ...FASENRA® (benralizumab) is an add-on maintenance treatment for patients 12 and older who are diagnosed with severe eosinophilic asthma.
- Fasenra: Uses, Dosage, Side Effects, Warnings - Drugs.comFasenra (benralizumab) is an injectable monoclonal antibody that affects the body's immune system by binding to the interleukin-5 receptor. It may be used as add-on therapy to treat severe eosinophilic asthma (SEA) in adults and children aged 6 years and older. Fasenra is for people whose asthma is not well controlled with other medications.
- Benralizumab - WikipediaBenralizumab, sold under the brand name Fasenra, is a monoclonal antibody directed against the alpha chain of the interleukin-5 receptor . It was developed by MedImmune for the treatment of asthma. Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016.
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe ...Benralizumab is a humanized, afucosylated (engineered to eliminate fucose sugars from the oligosaccharides in the Fc region) monoclonal antibody directed against the alpha subunit of the...
More
